Anticholinergics have unclear benefits in overactive bladder syndrome
Anticholinergic agents benefit some patients with overactive bladders,
but the effects may be of limited clinical importance. Herbison and
colleagues (p 841) conducted a systematic review of 32 randomised
controlled trials that compared anticholinergics with placebo in
treating overactive bladder syndrome. The study found that patients
taking anticholinergics had one less incontinent episode and one less
need to void every two days than patients taking placebo. They were
more likely to have dry mouth, the most common side effect of treatment.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
StumbleUpon 
Technorati What's this?
Relevant Article
- Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review
- Peter Herbison, Jean Hay-Smith, Gaye Ellis, and Kate Moore
BMJ 2003 326: 841-844.[Abstract] [Full Text] [PDF]
This Article
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Related Content
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
There are no rapid responses for this article. Print issues
